These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 103491

  • 1. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR, Clark PR, Shuster JJ, Baer H.
    Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.
    Roy I, Bach V, Thadepalli H.
    Antimicrob Agents Chemother; 1977 Feb; 11(2):258-61. PubMed ID: 848931
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP, Briedis DJ, Robson HG, Conterato JP.
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [Abstract] [Full Text] [Related]

  • 4. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD, Levison ME, Kaye D.
    Infection; 1980 Mar; 8(3):121-2. PubMed ID: 6448229
    [Abstract] [Full Text] [Related]

  • 5. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN, Thornsberry C, Barry AL, Fuchs PC, Gavan TL, Gerlach EH.
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [Abstract] [Full Text] [Related]

  • 6. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C, Sageaux JC, Bebear C, Latrille J.
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ, Prior RB.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [Abstract] [Full Text] [Related]

  • 8. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC, Gavan TL, Gerlach EH, Jones RN, Barry AL, Thornsberry C.
    Am J Med Sci; 1977 Aug; 274(3):255-63. PubMed ID: 610415
    [Abstract] [Full Text] [Related]

  • 9. In vitro studies of piperacilin, a new semisynthetic penicillin.
    Winston DJ, Wang D, Young LS, Martin WJ, Hewitt WL.
    Antimicrob Agents Chemother; 1978 Jun; 13(6):944-50. PubMed ID: 677861
    [Abstract] [Full Text] [Related]

  • 10. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
    Phaneuf D, Neu HC.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
    [Abstract] [Full Text] [Related]

  • 11. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
    Parry MF, Neu HC.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
    [Abstract] [Full Text] [Related]

  • 12. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [Abstract] [Full Text] [Related]

  • 13. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Reimer LG, Mirrett S, Reller LB.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
    [Abstract] [Full Text] [Related]

  • 14. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
    Henderson DK, Chow AW, Guze LB.
    Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of the Bacteroides fragilis group of anaerobes to carbenicillin and ticarcillin.
    Garcia Rodriguez JA, Garcia Sanchez JE, Gomez Garcia AC, Prieto Prieto J.
    J Antimicrob Chemother; 1978 May; 4(3):284-6. PubMed ID: 670123
    [No Abstract] [Full Text] [Related]

  • 16. Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1976 Aug; 10(2):241-4. PubMed ID: 984764
    [Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.
    Neu HC, Garvey GJ.
    Antimicrob Agents Chemother; 1975 Oct; 8(4):457-62. PubMed ID: 1190752
    [Abstract] [Full Text] [Related]

  • 18. Piperacillin susceptibility tests by the single-disk agar diffusion technique.
    Barry AL, Thornsberry C, Badal RE, Baker CN, Jones RN, Gerlach EH.
    Antimicrob Agents Chemother; 1979 Sep; 16(3):378-85. PubMed ID: 507794
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of ticarcillin, carbenicillin and ampicillin against some gram-negative bacilli.
    Legakis NJ, Papavassiliou J.
    J Antibiot (Tokyo); 1975 Nov; 28(11):912-9. PubMed ID: 811636
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin.
    McGowan JE, Terry PM.
    Antimicrob Agents Chemother; 1979 Jan; 15(1):137-39. PubMed ID: 426501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.